Altaire Pharmaceuticals, Inc. v. Paragon Bioteck, Inc.

N OTE: This order is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
ALTAIRE PHARMACEUTICALS, INC.,
Appellant
v.
PARAGON BIOTECK, INC.,
Appellee
______________________
2017-1487
______________________
Appeal from the United States Patent and Trademark
Office, Patent Trial and Appeal Board in No. PGR2015-
00011.
______________________
Before O’MALLEY , SCHALL , and WALLACH , Circuit Judges.
P ER C URIAM .
O R D E R
Upon consideration of the parties’ September 24, 2018
response to this court’s order to show cause,
I T I S O RDERED T HAT :
We do not typically vacate an issued opinion. Cf. Tivo
Inc. v. EchoStar Corp., 429 F. App’x 975, 976 (Fed. Cir.
2011). However, in light of the parties’ settlement in this
case, the court shall modify the precedential opinion and

-- 1 of 2 --

ALTAIRE PHARM ., INC. v. PARAGON BIOTECK, INC. 2
judgment issued May 2, 2018, by vacating only the por-
tion that orders remand to the U.S. Patent and Trade-
mark Office’s Patent Trial and Appeal Board. Any
citation to our underlying opinion should read: Altaire
Pharmaceuticals, Inc. v. Paragon Bioteck, Inc., 889 F.3d
1274 (Fed. Cir. 2018), remand order modified by stipula-
tion, [this order].
F OR THE COURT
October 2, 2018 /s/ Peter R. Marksteiner
Date Peter R. Marksteiner
Clerk of Court

-- 2 of 2 --